BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee H, Shim EH, You S. Immunodominance hierarchy of influenza subtype-specific neutralizing antibody response as a hurdle to effectiveness of polyvalent vaccine. Hum Vaccin Immunother 2018;14:2537-9. [PMID: 29852081 DOI: 10.1080/21645515.2018.1482172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Abreu RB, Kirchenbaum GA, Clutter EF, Sautto GA, Ross TM. Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination. JCI Insight 2020;5:132155. [PMID: 31794433 DOI: 10.1172/jci.insight.132155] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
2 Allen JD, Ross TM. Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019. J Virol 2022;:e0165221. [PMID: 35289635 DOI: 10.1128/jvi.01652-21] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Jang H, Ross TM. Influence of the H1N1 influenza pandemic on the humoral immune response to seasonal flu vaccines. PLoS One 2021;16:e0258453. [PMID: 34679115 DOI: 10.1371/journal.pone.0258453] [Reference Citation Analysis]
4 Rakibuzzaman A, Kolyvushko O, Singh G, Nara P, Piñeyro P, Leclerc E, Pillatzki A, Ramamoorthy S. Targeted Alteration of Antibody-Based Immunodominance Enhances the Heterosubtypic Immunity of an Experimental PCV2 Vaccine. Vaccines (Basel) 2020;8:E506. [PMID: 32899842 DOI: 10.3390/vaccines8030506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]